So your prescriber can help match you with the option that best fits your needs: Ozempic: Approved for Type 2 diabetes and to lower the risk of serious cardiovascular and kidney-related problems in certain people Wegovy: Approved for weight loss and to lower the risk of serious cardiovascular problems if you have heart disease and a larger body size Mounjaro: Approved for Type 2 diabetes Zepbound : Approved for weight loss and moderate-to-severe obstructive sleep apnea (OSA) Be prepared to share details about your current compounded GLP-1 prescription
In 2023 and early 2024, Novo Nordisk reported manufacturing constraints that limited Ozempic and Wegovy stock at retail pharmacies
In addition, cytokines involved in ICD (such as IFN- and IL-1) and death receptors on the cell surface (such as FAS and TNFR) can also be used as key factors affecting the immune effect (100, 101)
J Natl Cancer Inst Monogr
At Grain by Grain, we tailor your nutrition plan to support both the medical and metabolic goals of GLP-1 treatment not just weight loss
Semaglutide GLP-1 works by mimicking a naturally occurring hormone that targets areas of the brain involved in regulating appetite and food intake, enhancing the feeling of fullness after meals
